There is more regulatory interest in ambient products and growing opportunities for solution providers to enter this market. In this presentation Ian Holloway, Manager, Defective Medicines Report Centre, Medicines and Healthcare Products Regulatory Agency (MHRA), discusses the expectations and documenting for ambient or CRT products, regulatory expectations for qualification or validation and stability studies versus shipping studies.
RECOMMENDED
Upcoming Events
Pharmaceutical Launch Excellence Summit
1 - 3 December, 2026
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More
SmartLab Exchange Europe
22 - 23 February 2027
Leonardo Royal Hotel Amsterdam, Netherlands
Register Now |
View Agenda |
Learn More
Pharma Contract Manufacturing
9 - 11 March 2027
Berlin, Germany
Register Now |
View Agenda |
Learn More